The Influence of Raltegravir (MK-0518) on the Pharmacokinetics of Single-Dose Lamotrigine in Healthy Male Subjects (GRANOLA).

Trial Profile

The Influence of Raltegravir (MK-0518) on the Pharmacokinetics of Single-Dose Lamotrigine in Healthy Male Subjects (GRANOLA).

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2012

At a glance

  • Drugs Lamotrigine; Raltegravir
  • Indications Epilepsy; HIV-1 infections; Seizures
  • Focus Pharmacokinetics
  • Acronyms GRANOLA
  • Most Recent Events

    • 15 Mar 2012 Planned end date changed from 1 Oct 2008 to 21 Dec 2011 as reported by European Clinical Trials Database.
    • 15 Mar 2012 Actual initiation date changed from Feb 2008 to Jan 2008 as reported by European Clinical Trials Database.
    • 21 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top